 Heubach Colorants India Ltd Q2 FY2026 PAT at Rs. 16.28 crores
Heubach Colorants India Ltd Q2 FY2026 PAT at Rs. 16.28 crores Indiabulls Ltd Q2 FY2025-26 consolidated profit at Rs. 0.71 crore
Indiabulls Ltd Q2 FY2025-26 consolidated profit at Rs. 0.71 crore LKP Securities Ltd consolidated Q2FY26 PAT lower at Rs. 2.66 crore
LKP Securities Ltd consolidated Q2FY26 PAT lower at Rs. 2.66 crore NTPC Green Energy Ltd Signs MoU with CtrlS Datacenter Limited for development of RE Projects
NTPC Green Energy Ltd Signs MoU with CtrlS Datacenter Limited for development of RE Projects Lemon Tree Hotels signs 11th property in Punjab
Lemon Tree Hotels signs 11th property in Punjab 
              Mumbai, October 19, 2006: Lupin Ltd today announced that Mr.Edward R.Roberts has joined the company's board as an Independent Director.
Mr.Roberts, a British Citizen, residing in Germany, is a 1959 pharmacy graduate from Leicester University. He has wide experience in the international pharma industry. He is the Chairman of the Board of "Biopartners", (a Swiss biotech company) and "Merz Pharma", (a well known German pharma company). He is also a member of the Board of "Icon", a listed US Contact Research Organisation. He is also an advisor to "Avista", a US private equity company.
Till the year 1998, he was the Head of Pharmaceuticals at 'E Merck', a leading German pharma company, prior to which he spent 27 years at 'Eli Lilly' was as President of 'Elanco', the agricultural division of 'Eli Lilly'.
Welcoming Mr.Robers on the Board, Dr.Desh Bandhu Gupta, Chairman, said "I am delighted that an internationally renowned person like Mr.Roberts has accepted our invitation to join the Board. His enormous experience and deep knowledge of the International pharma business will prove to be a valuable asset for Lupin."